(RTTNews) - MediWound Ltd. (MDWD) reported positive results from U.S. prospective, open-label, single-arm, phase 2 clinical study of EscharEx for the debridement of lower leg ulcers.

Schlieren / Zurich, Switzerland, 11 June, 2025 - Memo Therapeutics AG (or "MTx”), a late-stage biotechnology company developing antibody-based therapies for viral infections and cancer, has published ...